6 Firms Steer Trio Of Biotech IPOs Totaling $584M
Law360 (July 10, 2020, 5:11 PM EDT) — Three venture-backed biotechnology companies went public Friday after raising a combined $584 million in initial public offerings amid a robust market, guided by six law firms that either represented the companies or their underwriters, including two deals by Cooley LLP.
Cancer therapy maker Nkarta Inc., advised by O’Melveny & Myers LLP, led the companies with a $252 million IPO. South San Francisco-based Nkarta sold 14 million shares at $18 each, above its projected range of $16 to $17, which was raised from its initial estimate of $14 to $16.
Cooley-advised oncology firm Poseida Therapeutics Inc., which is developing treatments for multiple…